About
Scope & Aims
Editorial office
Editorial board
Ethical standards and procedures
Abstracting and indexing
Contact
Articles & Issues
Current issue
Articles in press
Archive
For Authors
General rules
Ethics in publishing
Guide for authors
Templates
Publication charge
For Reviewers
Our reviewers
Ethics in publishing
Guide for reviewers
Books and Events
Books
Events
ORIGINAL PAPER
Applicability of the Minimal Clinically Important Difference in the activities
of daily living, motor sections, and quality of life in individuals with Parkinson’s
disease after aquatic physical therapy intervention: a pilot study
1
Department of Physical Therapy Prevention and Rehabilitation, Federal University of Paraná – Polytechnic Center, Paraná, Brazil
2
Ana Carolina Moura Xavier Hospital Rehabilitation Center, Paraná, Brazil
Submission date: 2020-12-24
Acceptance date: 2021-03-03
Publication date: 2023-06-01
Physiother Quart. 2023;31(2):34-38
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Define the applicability of the Minimal Clinically Important Difference (MCID) in the activities of daily living (ADLs), motor sections, and quality of life (QOL) in people with Parkinson’s disease (PD) after an aquatic physical therapy (APT) intervention.
Methods:
A total of 11 individuals participated in this pilot study. They were of both genders, mean age 70.73 ± 10.67 years, diagnosed with idiopathic PD, and classified in stages 1 to 4 on the Hoehn & Yahr scale. The volunteers were assessed, before and after the APT intervention, with the Unified Parkinson’s Disease Rating Scale (UPDRS), sections II (ADLs) and III (motor sections), in addition to Parkinson’s Disease Questionnaire-39 (PDQ-39) (QOL). The APT comprises multicomponent exercises developed throughout a 12-week period, in twice-a-week 40-minute sessions. The data were analysed with the Wilcoxon test and MCID values described in the literature.
Results:
There were no statistically significant changes in the results found (p > 0.05), but they neared the MCID values in both scales.
Conclusions:
Different forms to analyse a study are necessary to elucidate the applicability of MCID values in detecting an improvement or worsening in the clinical condition of people with PD.
Define the applicability of the Minimal Clinically Important Difference (MCID) in the activities of daily living (ADLs), motor sections, and quality of life (QOL) in people with Parkinson’s disease (PD) after an aquatic physical therapy (APT) intervention.
Methods:
A total of 11 individuals participated in this pilot study. They were of both genders, mean age 70.73 ± 10.67 years, diagnosed with idiopathic PD, and classified in stages 1 to 4 on the Hoehn & Yahr scale. The volunteers were assessed, before and after the APT intervention, with the Unified Parkinson’s Disease Rating Scale (UPDRS), sections II (ADLs) and III (motor sections), in addition to Parkinson’s Disease Questionnaire-39 (PDQ-39) (QOL). The APT comprises multicomponent exercises developed throughout a 12-week period, in twice-a-week 40-minute sessions. The data were analysed with the Wilcoxon test and MCID values described in the literature.
Results:
There were no statistically significant changes in the results found (p > 0.05), but they neared the MCID values in both scales.
Conclusions:
Different forms to analyse a study are necessary to elucidate the applicability of MCID values in detecting an improvement or worsening in the clinical condition of people with PD.
REFERENCES (30)
1.
Fontoura VCB, Macêdo JGF, da Silva LP, da Silva LB, Coriolano MGWS, Monteiro D. The role of rehabilitation with virtual reality in functional ability and quality of life of individuals with Parkinson’s disease. Acta Fisiatr. 2017;24(2):86–91; doi: 10.5935/0104-7795.20170017.
2.
Simonet C, Schrag A, Lees AJ, Noyce AJ. The motor prodromes of Parkinson’s disease: from bedside observation to large-scale application. J Neurol. 2021;268(6):2099–2108; doi: 10.1007/s00415-019-09642-0.
3.
Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, et al. MDS Research criteria for prodromal Parkinson’s disease. Mov Disord. 2015;30(12):1600–1611; doi: 10.1002/mds.26431.
4.
Tibar H, Bayad KE, Bouhouche A, Haddou EHAB, Benomar A, Yahiaoui M, et al. Non-motor Symptoms of Parkinson’s disease and their impact on Quality of Life in a cohort of Moroccan patients. Front Neurol. 2018;9:170; doi: 10.3389/fneur.2018.00170.
5.
Stegemöller EL, Uzochukwu J, Shelley M. The relationship between repetitive finger movement and quality of life in Parkinson’s disease. Neurol Res. 2018;40(9):724–727; doi: 10.1080/01616412.2018.1473076.
6.
Yamaguchi B, Ferreira MP, Israel VL. Multidisciplinary care and the reduction of levodopa intake of patients with advanced Parkinson’s disease. Acta Fisiatr. 2016;23(4):197–200; doi: 10.5935/0104-7795.20160037.
7.
Yamaguchi B, Ferreira MP, Israel VL. Aquatic physiotherapy and Parkinson’s disease: effects on functional motor skills. Adv Parkinsons Dis. 2020;9:1–12; doi: 10.4236/apd.2020.91001.
8.
da Silva LP, Duarte MPS, de Souza CCB, Lins CCSA, Coriolano MGWS, Lins OG. Effects of mental practice associated with motor physical therapy on gait and risk of falls in Parkinson’s disease: a pilot study. Fisioter Pesqui. 2019;26(2):112–119; doi: 10.1590/1809-2950/17012926022019.
9.
Iucksch DD, Araujo LB, Novakoski KM, Yamaguchi B, Carneiro CF, Mélo TR, et al. Decoding the aquatic motor behavior: description and reflection on the functional movement. Acta Scientarium. 2020;42(1):e47129; doi: 10.4025/actascihealthsci.v42i1.47129.
10.
Pochmann D, Peccin PK, Silva IRV, Dorneles GP, Peres A, Nique S, et al. Cytokine modulation in response to acute and chronic aquatic therapy intervention in Parkinson disease individuals: a pilot study. Neurosci Lett. 2018;674:30–35; doi: 10.1016/j.neulet.2018.03.021.
11.
Carroll LM, Volpe D, Morris ME, Saunders J, Clifford AM. Aquatic exercise therapy for people with Parkinson’s disease: a randomized controlled trial. Arch Phys Med Rehabil. 2017;98(4):631–638; doi: 10.1016/j.apmr.2016.12.006.
12.
Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol. 2008;61(2):102–109; doi: 10.1016/j.jclinepi.2007.03.012.
13.
Schrag A, Sampaio C, Counsell N, Poewe W. Minimal clinically important change on the unified Parkinson’s disease rating scale. Mov Disord. 2006;21(8):1200–1207; doi: 10.1002/mds.20914.
14.
Sánchez-Ferro A, Matarazzo M, Martínez-Martín P, Martínez-Ávila JC, Cámara AGL, Giancardo L, et al. Minimal clinically important difference for UPDRS-III in daily practice. Mov Disord Clin Pract. 2018;5(4):448–450; doi: 10.1002/mdc3.12632.
15.
Wilkinson DT, Podlewska A, Sakel M. A durable gain in motor and non-motor symptoms of Parkinson’s disease following repeated caloric vestibular stimulation: a single-case study. NeuroRehabilitation. 2016;38(2):179–182; doi: 10.3233/NRE-161308.
16.
Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials. BMJ. 2010;340:698–702; doi: 10.1136/bmj.c332.
17.
Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427–442; doi: 10.1212/wnl.17.5.427.
18.
Mello MPB, Botelho ACG. Correlation of evaluation scales utilitized at Parkinson’s disease applied to physical therapy [in Portuguese]. Fisioter Mov. 2010;23:121–127; doi: 10.1590/S0103-51502010000100012.
19.
Keus SHJ, Munneke M, Graziano M, , Paltamaa J, Pelosin E, Domingos J, et al. European Physiotherapy Guideline for Parkinson’s Disease. KNGF/ParkinsonNet, the Netherlands; 2014.
20.
Israel VL, Pardo MBL. Hydrotherapy: application of an Aquatic Functional Assessment Scale (AFAS) in aquatic motor skills learning. Am Int J Contemp Res. 2014;4(2):42–52.
21.
Horwáth K, Aschermann Z, Kovács M, Makkos A, Harmat M, Janszky J, et al. Changes in Quality of Life in Parkinson’s disease: how large must they be to be relevant? Neuroepidemiology. 2017;48:1–8; doi: 10.1159/000455863.
22.
Carod-Artal FJ, Vargas AP, Martinez-Martin P. Determinants of Quality of Life in Brazilian patients with Parkinson’s disease. Mov Disord. 2007;22(1):1408–1415; doi: 10.1002/mds.21408.
23.
Kużdżał A, Wroński Z. Hydrotherapy in physiotherapy – a critical review of literature. Physiother Rev. 2020;24(2); doi: 10.5114/phr.2020.103019.
24.
Volpe D, Giantin MG, Maestri R, Frazzitta G. Comparing the effects of hydrotherapy and land-based therapy on balance in patients with Parkinson’s disease: a randomized controlled pilot study. Clin Rehabil. 2014;28(12):1210–1217; doi: 10.1177/0269215514536060.
25.
Ayán C, Cancela J. Feasibility of 2 different water-based exercise training programs in patients with Parkinson’s disease: a pilot study. Arch Phys Med Rehabil. 2012;93(10):1709–1714; doi: 10.1016/j.apmr.2012.03.029.
26.
Ahlskog JE. Does vigorous exercise have a neuroprotective effect in Parkinson’s disease? Neurology. 2011;77(3):288–294; doi: 10.1212/WNL.0b013e318225ab66.
27.
Villegas ILP, Israel VL. Effect of Ai-Chi method on the functional activities, quality of life and posture in patients with Parkinson’s disease. Top Geriatr Rehabil. 2014;30(4):282–289; doi: 10.1097/TGR.0000000000000039.
28.
Lana RC, Alvares LMRS, Nasciutti-Prudente C, Goulart FRP, Teixeira-Salmela LF, Cardoso FE. Perception of quality of life in individuals with Parkinson’s disease using the PDQ-39. Braz J Phys Ther. 2007;11(5):397–402; https://doi.org/10.1590/S1413-....
29.
Kuhlman GD, Flanigan JL, Sperling AS, Barrett MJ. Predictors of health-related quality of life in Parkinson’s disease. Parkinsonism Relat Disord. 2019;65:86–90; doi: 10.1016/j.parkreldis.2019.05.009.
30.
Kurt EE, Büyükturan B, Büyükturan O, Erdem HR, Tuncay F. Effects of Ai Chi on balance, quality of life, functional mobility, and motor impairment in patients with Parkinson’s disease. Disabil Rehabil. 2017;40(7):791–797; doi: 10.1080/09638288.2016.1276972.
Share
RELATED ARTICLE
| eISSN: | 2544-4395 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
